Characterizing telemedicine use in clinical immunology and allergy in Canada before the COVID-19 pandemic
Tóm tắt
There exists a geographic barrier to access CIA care for patients who live in rural communities; telemedicine may bridge this gap in care. Herein we characterized the use of telemedicine in CIA at a population-based level and single centre. Before the COVID-19 pandemic, telemedicine care was provided via the Ontario Telemedicine Network (OTN) in Ontario, Canada. Descriptive data were collected from the OTN administrative database and from electronic medical records at a single academic centre during 2014 to 2019. The potential distance travelled and time saved by telemedicine visits were calculated using postal codes. A total of 1298 telemedicine visits was conducted over OTN, with an average of 216 visits per year. Only 11% of the allergists/immunologists used telemedicine to provide care before the COVID-19 pandemic. In the single centre that provided the majority of the telemedicine care, 66% patients were female and the overall mean age was 46. The most common diagnosis was immunodeficiency (40%), followed by asthma (13%) and urticaria (11%). Most patients required at least one follow-up via telemedicine. The average potential two-way distance travelled per visit was 718 km and the average potential time travelled in total was 6.6 h. Telemedicine was not widely used by allergists/immunologists in Ontario, Canada before the COVID-19 pandemic. It could offer a unique opportunity to connect patients who live in remote communities and allergists/immunologists who practice in urban centres in Canada. Independent of the current pandemic, our study further highlights the need for more physicians to adopt and continue telemedicine use as well as for healthcare agencies to support its use as a strategic priority once the pandemic is over.
Tài liệu tham khảo
Murphy RL Jr, Bird KT. Telediagnosis: a new community health resource. Am J Public Health. 1974;64:113–9.
Portnoy JM, Elliott T. Tele-allergy: here today and rapidly advancing. J Allergy Clin Immunol Pract. 2019;7:1022–3.
Phadke NA, Wolfson AR, Mancini C, Fu X, Goldstein SA, Ngo J, et al. Electronic consultations in allergy/immunology. J Allergy Clin Immunol Pract. 2019;7:2594–602.
The College of Surgeons and Physicians of Ontario (CPSO). Ontario, Canada; 2019. https://doctors.cpso.on.ca/. Accessed 15 Dec 2019.
Census of the Population, 2016. Statistics Canada; 2017. https://www12.statcan.gc.ca/census-recensement/2016/dp-pd/index-eng.cfm. Accessed 15 Mar 2021.
Taylor L, Waller M, Portnoy JM. Telemedicine for allergy services to rural communities. J Allergy Clin Immunol Pract. 2019;7(8):2554–9.
Ontario Telemedicine Network. Ontario, Canada; 2021. https://otn.ca/about/. Accessed 15 Mar 2020.
2016 Census. Statistics Canada website. 2019. https://www12.statcan.gc.ca/census recensement/index-eng.cfm. Accessed 15 Dec 2019.
Waibel KH, Bickel RA, Brown T. Outcomes from a regional synchronous teleallergy service. J Allergy Clin Immunol Pract. 2019;7:1017–21.
Waibel KH. Synchronous telehealth for outpatient allergy consultations: a 2-year regional experience. Ann Allergy Asthma Immunol. 2016;116:571-575.e1.
Canadian specialty profiles. Canadian Medical Association website. 2020. https://www.cma.ca/canadian-specialty-profiles. Accessed 1 Feb 2020.
Neimanis I, Gaebel K, Dickson R, et al. Referral processes and wait times in primary care. Can Fam Physician. 2017;63(8):619–24.
Meltzer EO. Quality of life in adults and children with allergic rhinitis. J Allergy Clin Immunol. 2001;108(1 Suppl):S45–53.
Brown W, Odenthal D. The uses of telemedicine to improve asthma control. J Allergy Clin Immunol Pract. 2015;3:300–1.
Portnoy JM, Waller M, De Lurgio S, Dinakar C. Telemedicine is as effective as in-person visits for patients with asthma. Ann Allergy Asthma Immunol. 2016;117:241–5.